Xinyuan Real Estate Co., Ltd. (ADR)  

(Public, NYSE:XIN)   Watch this stock  
Find more results for XIN
2.73
+0.03 (1.11%)
Oct 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 2.72 - 2.77
52 week 2.64 - 7.44
Open 2.75
Vol / Avg. 125,736.00/291,807.00
Mkt cap 214.39M
P/E 2.60
Div/yield 0.05/7.33
EPS 1.05
Shares 156.01M
Beta 1.40
Inst. own 6%
Nov 8, 2014
Q3 2014 Xinyuan Real Estate Co Ltd Earnings Release (Estimated) Add to calendar
Aug 15, 2014
Q2 2014 Xinyuan Real Estate Co., Ltd. Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 4.10% 14.07%
Operating margin 4.58% 23.81%
EBITD margin - 24.16%
Return on average assets 1.02% 6.40%
Return on average equity 2.90% 14.57%
Employees 668 -
CDP Score - -

Address

27F, China Central Place, Tower II 79 Jianguo Road, Chaoyang District
BEIJING, BEJ 100025
China
+86-10-85889200 (Phone)
+86-10-85889300 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Xinyuan Real Estate Co., Ltd. (Xinyuan) is a developer of large-scale residential real estate projects aimed at providing middle-income consumers with a comfortable and convenient community lifestyle. Xinyuan has expanded its network to cover a total population of over 64.7 million people in eight selected cities, consisting Beijing, Hefei, Jinan, Kunshan, Suzhou, Zhengzhou, Xuzhou and Chengdu. The Company's United States development arm, XIN Development Group International, Inc. (XIN), is a real estate residential developer that entered the United States market with three projects in 2012. XIN�s products portfolio consists of multiple rise buildings, sub-high-rise buildings and high-rise buildings, together with auxiliary services and amenities, such as retail outlets, leisure and health facilities, kindergartens and schools. In April 2014, the Company acquired parcel of land in Shanghai by purchasing 100% interest of local project development co.

Officers and directors

Yong Zhang Chairman of the Board
Age: 49
Bio & Compensation  - Reuters
Xinqi Wang Chief Executive Officer, Director
Bio & Compensation  - Reuters
Manbo He Chief Financial Officer
Age: 45
Bio & Compensation  - Reuters
Yinfei Hao Executive Vice President - legal and external audit, Independent Director
Age: 63
Bio & Compensation  - Reuters
Yuyan Yang Vice President, Director
Age: 50
Bio & Compensation  - Reuters
Helen Zhang Financial Controller
Bio & Compensation  - Reuters
Yong Cui Ph.D. Director
Age: 38
Bio & Compensation  - Reuters
Thomas H. R. Gurnee Director
Age: 62
Bio & Compensation  - Reuters
Yumin Liang Director
Bio & Compensation  - Reuters
Huai Chen Independent Director
Age: 62
Bio & Compensation  - Reuters